Microba Historical Balance Sheet

MAP Stock

0.19 0.01 5.56%

Trend analysis of Microba Life Sciences balance sheet accounts such as Total Current Liabilities of 13 M provides information on Microba Life's total assets, liabilities, and equity, which is the actual value of Microba Life Sciences to its prevalent stockholders. By breaking down trends over time using Microba Life balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Microba Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Microba Life Sciences is a good buy for the upcoming year.

Microba Life Inventory

2.36 Million

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microba Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Microba Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Microba Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Microba Life Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Microba Life and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Microba currently owns. An asset can also be divided into two categories, current and non-current.

Microba Life Balance Sheet Chart

At this time, Microba Life's Long Term Debt Total is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 4.7 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 27.2 M in 2024.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities

Add Fundamental

Total Assets

Total assets refers to the total amount of Microba Life assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Microba Life Sciences books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Microba Life balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Microba Life Sciences are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Microba Life's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Microba Life Sciences current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Microba Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	1.3M	1.1M	1.6M	968.7K
Total Assets	39.5M	47.0M	58.0M	34.4M

Short Long Term Debt Total Total Assets

Microba Life balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment
Total Assets		0.96	0.84	0.87	0.99	0.95	0.83	-0.85	-0.92	0.86	0.86	0.7	0.62	0.86	0.91	0.85	0.21	0.68	0.74	0.73	0.84	0.94	0.98	0.73	1.0	0.94
Short Long Term Debt Total	0.96		0.76	0.84	0.95	0.98	0.89	-0.81	-0.87	0.8	0.83	0.68	0.6	0.83	0.87	0.79	0.43	0.68	0.7	0.55	0.81	0.89	0.98	0.7	0.95	0.99
Other Current Liab	0.84	0.76		0.98	0.8	0.78	0.68	-0.62	-0.97	0.99	0.63	0.9	0.85	0.63	0.96	0.91	-0.1	0.87	0.94	0.79	0.97	0.74	0.83	0.93	0.86	0.68
Total Current Liabilities	0.87	0.84	0.98		0.84	0.84	0.79	-0.67	-0.99	0.97	0.68	0.92	0.87	0.68	0.97	0.89	0.06	0.9	0.95	0.71	0.99	0.78	0.88	0.94	0.89	0.77
Total Stockholder Equity	0.99	0.95	0.8	0.84		0.92	0.82	-0.91	-0.89	0.84	0.92	0.64	0.55	0.92	0.9	0.79	0.26	0.62	0.68	0.72	0.8	0.97	0.96	0.68	0.98	0.94
Property Plant And Equipment Net	0.95	0.98	0.78	0.84	0.92		0.81	-0.71	-0.87	0.82	0.73	0.76	0.7	0.73	0.87	0.88	0.39	0.76	0.76	0.51	0.84	0.82	0.96	0.77	0.93	0.96
Current Deferred Revenue	0.83	0.89	0.68	0.79	0.82	0.81		-0.76	-0.83	0.66	0.77	0.59	0.52	0.77	0.75	0.61	0.3	0.59	0.65	0.52	0.75	0.82	0.9	0.6	0.85	0.83
Net Debt	-0.85	-0.81	-0.62	-0.67	-0.91	-0.71	-0.76		0.73	-0.66	-1.0	-0.39	-0.27	-1.0	-0.77	-0.47	-0.36	-0.36	-0.43	-0.65	-0.6	-0.98	-0.82	-0.42	-0.82	-0.84
Retained Earnings	-0.92	-0.87	-0.97	-0.99	-0.89	-0.87	-0.83	0.73		-0.96	-0.74	-0.88	-0.82	-0.74	-0.98	-0.89	-0.07	-0.86	-0.92	-0.75	-0.98	-0.84	-0.92	-0.9	-0.93	-0.81
Accounts Payable	0.86	0.8	0.99	0.97	0.84	0.82	0.66	-0.66	-0.96		0.67	0.9	0.84	0.67	0.99	0.91	0.02	0.87	0.92	0.75	0.96	0.77	0.85	0.92	0.88	0.75
Cash	0.86	0.83	0.63	0.68	0.92	0.73	0.77	-1.0	-0.74	0.67		0.4	0.29	1.0	0.78	0.49	0.37	0.38	0.44	0.65	0.61	0.98	0.84	0.44	0.84	0.86
Non Current Assets Total	0.7	0.68	0.9	0.92	0.64	0.76	0.59	-0.39	-0.88	0.9	0.4		0.99	0.4	0.85	0.9	0.05	1.0	0.99	0.48	0.96	0.52	0.7	1.0	0.72	0.61
Non Currrent Assets Other	0.62	0.6	0.85	0.87	0.55	0.7	0.52	-0.27	-0.82	0.84	0.29	0.99		0.29	0.78	0.87	0.02	0.99	0.98	0.4	0.92	0.41	0.62	0.98	0.64	0.52
Cash And Short Term Investments	0.86	0.83	0.63	0.68	0.92	0.73	0.77	-1.0	-0.74	0.67	1.0	0.4	0.29		0.78	0.49	0.37	0.38	0.44	0.65	0.61	0.98	0.84	0.44	0.84	0.86
Net Receivables	0.91	0.87	0.96	0.97	0.9	0.87	0.75	-0.77	-0.98	0.99	0.78	0.85	0.78	0.78		0.87	0.13	0.83	0.88	0.75	0.95	0.86	0.91	0.88	0.92	0.83
Common Stock Shares Outstanding	0.85	0.79	0.91	0.89	0.79	0.88	0.61	-0.47	-0.89	0.91	0.49	0.9	0.87	0.49	0.87		-0.03	0.88	0.9	0.65	0.91	0.64	0.83	0.91	0.86	0.73
Long Term Debt Total	0.21	0.43	-0.1	0.06	0.26	0.39	0.3	-0.36	-0.07	0.02	0.37	0.05	0.02	0.37	0.13	-0.03		0.1	-0.03	-0.43	0.07	0.27	0.26	0.04	0.14	0.52
Non Current Liabilities Total	0.68	0.68	0.87	0.9	0.62	0.76	0.59	-0.36	-0.86	0.87	0.38	1.0	0.99	0.38	0.83	0.88	0.1		0.98	0.41	0.95	0.49	0.68	0.99	0.69	0.6
Inventory	0.74	0.7	0.94	0.95	0.68	0.76	0.65	-0.43	-0.92	0.92	0.44	0.99	0.98	0.44	0.88	0.9	-0.03	0.98		0.58	0.98	0.57	0.74	0.99	0.76	0.61
Other Current Assets	0.73	0.55	0.79	0.71	0.72	0.51	0.52	-0.65	-0.75	0.75	0.65	0.48	0.4	0.65	0.75	0.65	-0.43	0.41	0.58		0.64	0.74	0.68	0.52	0.77	0.49
Total Liab	0.84	0.81	0.97	0.99	0.8	0.84	0.75	-0.6	-0.98	0.96	0.61	0.96	0.92	0.61	0.95	0.91	0.07	0.95	0.98	0.64		0.72	0.84	0.97	0.86	0.74
Total Current Assets	0.94	0.89	0.74	0.78	0.97	0.82	0.82	-0.98	-0.84	0.77	0.98	0.52	0.41	0.98	0.86	0.64	0.27	0.49	0.57	0.74	0.72		0.92	0.56	0.92	0.9
Short Term Debt	0.98	0.98	0.83	0.88	0.96	0.96	0.9	-0.82	-0.92	0.85	0.84	0.7	0.62	0.84	0.91	0.83	0.26	0.68	0.74	0.68	0.84	0.92		0.72	0.98	0.95
Intangible Assets	0.73	0.7	0.93	0.94	0.68	0.77	0.6	-0.42	-0.9	0.92	0.44	1.0	0.98	0.44	0.88	0.91	0.04	0.99	0.99	0.52	0.97	0.56	0.72		0.75	0.63
Common Stock	1.0	0.95	0.86	0.89	0.98	0.93	0.85	-0.82	-0.93	0.88	0.84	0.72	0.64	0.84	0.92	0.86	0.14	0.69	0.76	0.77	0.86	0.92	0.98	0.75		0.91
Property Plant Equipment	0.94	0.99	0.68	0.77	0.94	0.96	0.83	-0.84	-0.81	0.75	0.86	0.61	0.52	0.86	0.83	0.73	0.52	0.6	0.61	0.49	0.74	0.9	0.95	0.63	0.91

Click cells to compare fundamentals

Microba Life Account Relationship Matchups

Microba Life balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.8M	18.5M	39.5M	47.0M	58.0M	34.4M
Short Long Term Debt Total	563.6K	269.0K	1.3M	1.1M	1.6M	968.7K
Other Current Liab	988.1K	1.7M	1.1M	3.9M	5.3M	5.5M
Total Current Liabilities	2.8M	3.4M	5.3M	7.8M	12.4M	13.0M
Total Stockholder Equity	7.7M	14.9M	33.5M	38.6M	41.2M	27.2M
Property Plant And Equipment Net	1.6M	1.2M	2.8M	2.6M	3.9M	2.5M
Current Deferred Revenue	1.1M	1.1M	2.6M	1.3M	2.2M	1.6M
Net Debt	(6.3M)	(12.8M)	(29.3M)	(30.9M)	(19.3M)	(20.3M)
Retained Earnings	(12.2M)	(19.7M)	(31.2M)	(43.9M)	(63.8M)	(60.6M)
Accounts Payable	392.3K	353.5K	813.2K	3.0M	3.7M	3.9M
Cash	6.9M	13.0M	30.6M	32.0M	20.9M	21.0M
Non Current Assets Total	2.7M	2.3M	3.7M	5.4M	25.8M	27.1M
Cash And Short Term Investments	6.9M	13.0M	30.6M	32.0M	20.9M	21.0M
Net Receivables	622.8K	376.3K	3.4M	7.2M	8.1M	8.5M
Long Term Debt Total	245.4K	66.8K	483.8K	234.1K	269.2K	287.6K
Liabilities And Stockholders Equity	10.8M	18.5M	39.5M	47.0M	58.0M	34.4M
Non Current Liabilities Total	260.6K	110.4K	678.6K	404.1K	4.5M	4.7M
Inventory	340.8K	513.3K	360.0K	644.4K	2.2M	2.4M
Other Current Assets	244.6K	1.0M	204.4K	1.6M	1.0M	781.9K
Other Stockholder Equity	622.9K	1.2M	78.2K	2.1M	2.4M	2.5M
Total Liab	3.1M	3.5M	5.9M	8.2M	16.8M	17.7M
Total Current Assets	8.1M	16.2M	35.8M	41.5M	32.2M	26.7M
Accumulated Other Comprehensive Income	622.9K	1.2M	1.9M	2.1M	2.2M	1.5M
Cash And Equivalents	49.8K	50.3K	204.4K	12.4M	14.3M	15.0M
Short Term Debt	318.2K	202.3K	841.4K	901.7K	1.2M	660.2K
Intangible Assets	118.7K	246.3K	853.9K	2.8M	13.4M	14.1M
Common Stock	19.3M	33.5M	62.9M	80.4M	102.9M	58.1M
Property Plant Equipment	1.6M	1.2M	2.8M	2.6M	3.0M	2.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Microba Stock Analysis

When running Microba Life's price analysis, check to measure Microba Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microba Life is operating at the current time. Most of Microba Life's value examination focuses on studying past and present price action to predict the probability of Microba Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microba Life's price. Additionally, you may evaluate how the addition of Microba Life to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC